Cargando…

Clinical Utility of Cxbladder Monitor for Patients with a History of Urothelial Carcinoma: A Physician–Patient Real-World Clinical Data Analysis

INTRODUCTION: International guidelines advocate regular surveillance of patients following urothelial carcinoma (UC). A validated molecular diagnostic non-invasive urine test, Cxbladder Monitor, correctly identifies patients with a UC history who have low-probability of recurrence. The present study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lough, Tony, Luo, Qingyang, O’Sullivan, Paul, Chemaslé, Christophe, Stotzer, Michael, Suttie, James, Darling, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359999/ https://www.ncbi.nlm.nih.gov/pubmed/32700139 http://dx.doi.org/10.1007/s40487-018-0059-5

Ejemplares similares

Clinical Utility of Cxbladder for the Diagnosis of Urothelial Carcinoma
por: Darling, David, et al.
Publicado: (2017)

Clinical utility of a non-invasive urine test for risk assessing patients with no obvious benign cause of hematuria: a physician-patient real world data analysis
por: Lough, Tony, et al.
Publicado: (2018)

An evaluation of the real world use and clinical utility of the Cxbladder Monitor assay in the follow-up of patients previously treated for bladder cancer
por: Koya, Madhusudan, et al.
Publicado: (2020)

A holistic comparative analysis of diagnostic tests for urothelial carcinoma: a study of Cxbladder Detect, UroVysion® FISH, NMP22® and cytology based on imputation of multiple datasets
por: Breen, Vivienne, et al.
Publicado: (2015)

The Diagnostic Performance of Cxbladder Resolve, Alone and in Combination with Other Cxbladder Tests, in the Identification and Priority Evaluation of Patients at Risk for Urothelial Carcinoma
por: Raman, Jay D., et al.
Publicado: (2021)

A segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria who have a low probability of urothelial carcinoma
por: Kavalieris, Laimonis, et al.
Publicado: (2015)

Comparing CxBladder to Urine Cytology as Adjunct to Cystoscopy in Surveillance of Non-muscle Invasive Bladder Cancer—A Pilot Study
por: Chai, C. A., et al.
Publicado: (2021)

Treating Japanese Patients With Pembrolizumab for Platinum-Refractory Advanced Urothelial Carcinoma in Real-World Clinical Practice
por: Furubayashi, Nobuki, et al.
Publicado: (2020)

Nationwide Study of Real-World Treatment Patterns and Clinical Outcomes in Patients with Metastatic Urothelial Carcinoma in Hungary
por: Maráz, Anikó, et al.
Publicado: (2023)

Immunotherapy for Urothelial Carcinoma: Focus on Clinical Utility of Nivolumab
por: Chiang, Ryan S, et al.
Publicado: (2022)

Genetic Instability Persists in Non-Neoplastic Urothelial Cells from Patients with a History of Urothelial Cell Carcinoma
por: de Castro Marcondes, João Paulo, et al.
Publicado: (2014)

Clinical Significance of Survivin Expression in Patients with Urothelial Carcinoma
por: Chen, Hsin-An, et al.
Publicado: (2014)

Understanding Real-World Treatment Patterns and Clinical Outcomes among Metastatic Melanoma Patients in Alberta, Canada
por: O’Sullivan, Dylan E., et al.
Publicado: (2023)

The clinical utility of kinetic glomerular filtration rate
por: O'Sullivan, Eoin D., et al.
Publicado: (2017)

“Filler-ins” to Physicians: History of the Otolaryngology Training Program at Mayo Clinic
por: Bisco, Susan E., et al.
Publicado: (2020)

Evaluation of the clinical value of hematological parameters in patients with urothelial carcinoma of the bladder
por: Luo, Yuzhen, et al.
Publicado: (2018)

Clinical Evidence and Selecting Patients for Treatment with Erdafitinib in Advanced Urothelial Carcinoma
por: Sayegh, Nicolas, et al.
Publicado: (2022)

The history of the Ulster Obstetrical and Gynaecological Society.
por: O'Sullivan, J. F.
Publicado: (1994)

The history of obstetrics in Northern Ireland 1921-1992.
por: O'Sullivan, J. F.
Publicado: (2001)

The utility of clinical registries for guiding clinical practice in upper tract urothelial cancer: a narrative review
por: Kealey, Joshua, et al.
Publicado: (2023)

Outcome and prognostic factors in metastatic urothelial carcinoma patients receiving second-line chemotherapy: an analysis of real-world clinical practice data in Japan
por: Matsumoto, Ryuji, et al.
Publicado: (2018)

The end of medical confidentiality? Patients, physicians and the state in history
por: Rieder, Philip, et al.
Publicado: (2016)

Checkpoint Inhibition for Metastatic Urothelial Carcinoma After Chemotherapy—Real-World Clinical Impressions and Comparative Review of the Literature
por: Fuhrmann, Christian, et al.
Publicado: (2020)

A short history of the treatment of cancer in Northern Ireland.
por: O'Sullivan, John F.
Publicado: (2002)

The Utility of Fluorescence In Situ Hybridization for Detection of Bladder Urothelial Carcinoma in Routine Clinical Practice
por: Kwak, Kyung Won, et al.
Publicado: (2009)

The history and mystery of sacubitril/valsartan: From clinical trial to the real world
por: Zhang, Mingsong, et al.
Publicado: (2023)

Prognostic Utility of FBLN2 Expression in Patients With Urothelial Carcinoma
por: Li, Wei-Ming, et al.
Publicado: (2020)

Clinical Efficacy of Adjuvant Chemotherapy in Advanced Upper Tract Urothelial Carcinoma (pT3-T4): Real-World Data from the Taiwan Upper Tract Urothelial Carcinoma Collaboration Group
por: Lin, Chung-Yu, et al.
Publicado: (2022)

Physician support for diabetes patients and clinical outcomes
por: Gensichen, Jochen, et al.
Publicado: (2009)

uPAR Expression Pattern in Patients with Urothelial Carcinoma of the Bladder – Possible Clinical Implications
por: Dohn, Line Hammer, et al.
Publicado: (2015)

Clinical Behavior of Bladder Urothelial Carcinoma in Young Patients: A Single Center Experience
por: Sen, Volkan, et al.
Publicado: (2016)

Clinical Evaluation of Avelumab in the Treatment of Advanced Urothelial Carcinoma: Focus on Patient Selection and Outcomes
por: Ten Eyck, Jennifer E, et al.
Publicado: (2022)

The association between NOTCH3 expression and the clinical outcome in the urothelial bladder cancer patients
por: Petrović, Ana Ristić, et al.
Publicado: (2022)

Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab
por: Takahashi, Shuhei, et al.
Publicado: (2022)

Real World Haskell
por: O'Sullivan, Bryan, et al.
Publicado: (2008)

Can Emergency Physicians Perform Carotid Artery Point-of-Care Ultrasound to Detect Stenosis in Patients with TIA and Stroke? A Pilot Study
por: Suttie, Robert, et al.
Publicado: (2020)

World history /
por: Barnes. Ian

Real-World Treatment Patterns, Clinical Outcomes, and Health Care Resource Utilization in Extensive-Stage Small Cell Lung Cancer in Canada
por: O’Sullivan, Dylan E., et al.
Publicado: (2021)

Cystitis: From Urothelial Cell Biology to Clinical Applications
por: Lee, Gilho, et al.
Publicado: (2014)

Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder
por: Minato, Akinori, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2elc0bchefi9i5dv09pn2p202j